GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Apex Biotechnology 1733.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

28.75

-0.35%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.94bn

FY2016FY2025

Net income

TWD 163.0m

FY2016FY2025

Free cash flow

TWD 148.9m

FY2016FY2025

Shareholders' equity

TWD 1.87bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.94bnTWD 1.85bnTWD 1.68bnTWD 2.24bnTWD 2.13bnTWD 2.01bnTWD 2.20bnTWD 2.04bnTWD 1.80bnTWD 1.76bn
Gross profitTWD 538.7mTWD 521.3mTWD 531.1mTWD 576.8mTWD 571.5mTWD 452.2mTWD 590.6mTWD 560.1mTWD 431.5mTWD 476.8m
Research and developmentTWD 147.3mTWD 161.5mTWD 163.3mTWD 165.4mTWD 153.3mTWD 150.8mTWD 155.1mTWD 116.4mTWD 101.3mTWD 93.0m
Operating incomeTWD 140.7mTWD 130.1mTWD 141.7mTWD 205.0mTWD 194.0mTWD 120.5mTWD 172.9mTWD 227.3mTWD 161.0mTWD 60.2m
Net incomeTWD 163.0mTWD 128.0mTWD 115.8mTWD 181.8mTWD 202.2mTWD 94.8mTWD 113.9mTWD 95.1mTWD 85.6mTWD 3.2m
Diluted earnings per share1.631.281.161.822.510.941.160.960.850.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.42bnTWD 2.42bnTWD 2.30bnTWD 2.51bnTWD 2.67bnTWD 2.65bnTWD 2.81bnTWD 2.55bnTWD 2.70bnTWD 2.50bn
Cash and short-term investmentsTWD 644.4mTWD 598.8mTWD 443.9mTWD 397.5mTWD 631.2mTWD 823.0mTWD 803.0mTWD 402.0mTWD 697.4mTWD 611.6m
Total liabilitiesTWD 545.3mTWD 595.7mTWD 500.1mTWD 696.8mTWD 916.9mTWD 1.01bnTWD 1.14bnTWD 901.7mTWD 1.03bnTWD 768.5m
DebtTWD 148.9mTWD 166.2mTWD 180.8mTWD 243.9mTWD 343.3mTWD 571.8mTWD 667.3mTWD 479.1mTWD 652.2mTWD 415.1m
Shareholders' equityTWD 1.87bnTWD 1.82bnTWD 1.80bnTWD 1.82bnTWD 1.75bnTWD 1.65bnTWD 1.68bnTWD 1.64bnTWD 1.66bnTWD 1.73bn
Shares outstanding100m100m100m100m81m100m98m99m100m126m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 164.1mTWD 328.7mTWD 230.4mTWD 26.6mTWD 179.9mTWD 280.6mTWD 462.5mTWD 67.6mTWD 70.8mTWD 298.1m
Capital spending−TWD 15.3m−TWD 29.6m−TWD 25.0m−TWD 40.2m−TWD 26.2m−TWD 48.3m−TWD 56.6m−TWD 75.3m−TWD 26.8m−TWD 38.5m
Free cash flowTWD 148.9mTWD 299.0mTWD 205.4m−TWD 13.6mTWD 153.7mTWD 232.3mTWD 405.9m−TWD 7.7mTWD 44.1mTWD 259.6m
Dividends paid−TWD 119.9m−TWD 109.9m−TWD 139.9m−TWD 129.9m−TWD 109.3m−TWD 109.9m−TWD 84.7m−TWD 149.6m−TWD 149.6m−TWD 223.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 470.7mTWD 519.7mTWD 439.0mTWD 437.2mTWD 509.9mTWD 558.8mTWD 454.0mTWD 509.6m
Gross profitTWD 158.3mTWD 175.7mTWD 132.4mTWD 100.9mTWD 136.9mTWD 162.7mTWD 151.0mTWD 143.9m
Operating incomeTWD 44.6mTWD 87.2mTWD 33.2mTWD 8.0mTWD 43.3mTWD 57.0mTWD 48.1mTWD 47.3m
Net incomeTWD 36.8mTWD 81.4mTWD 50.2mTWD 22.1mTWD 28.7mTWD 62.0mTWD 38.5mTWD 33.1m
Diluted earnings per share0.370.810.500.220.290.620.380.33
Cash from operationsTWD 164.0mTWD 26.0mTWD 81.0mTWD 5.0mTWD 80.0m−TWD 11.0mTWD 145.0mTWD 55.0m
Capital spending−TWD 2.0m−TWD 9.0m−TWD 5.0m−TWD 2.0m−TWD 2.0m−TWD 5.0m−TWD 9.0m−TWD 10.0m
Free cash flowTWD 162.0mTWD 17.0mTWD 76.0mTWD 3.0mTWD 78.0m−TWD 16.0mTWD 136.0mTWD 45.0m
Total assetsTWD 2.55bnTWD 2.49bnTWD 2.42bnTWD 2.31bnTWD 2.40bnTWD 2.44bnTWD 2.42bnTWD 2.34bn
Cash and short-term investmentsTWD 814.9mTWD 667.9mTWD 644.4mTWD 561.1mTWD 674.7mTWD 594.8mTWD 598.8mTWD 466.8m
DebtTWD 43.4mTWD 56.0mTWD 54.6mTWD 46.4mTWD 43.0mTWD 51.3mTWD 52.2mTWD 42.0m
Shareholders' equityTWD 1.86bnTWD 1.82bnTWD 1.87bnTWD 1.81bnTWD 1.79bnTWD 1.77bnTWD 1.82bnTWD 1.78bn

Financial ratios

Data as of 25 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin27.7%28.1%31.7%25.7%26.8%22.6%
Operating margin7.2%8.5%8.7%9.1%9.1%6.0%
Net margin8.4%6.9%6.9%8.1%9.5%4.7%
Return on equity8.7%7.0%6.4%10.0%11.5%5.8%
Return on assets6.7%5.3%5.0%7.2%7.6%3.6%
Free cash flow yield6.1%12.1%8.6%2.3%8.6%11.1%
Revenue growth5.0%10.5%-25.3%5.3%6.3%-8.8%
Earnings growth27.4%10.5%-36.3%-10.1%113.3%-16.7%
Current ratio3.87x3.44x3.93x2.90x2.24x1.91x
Debt to equity0.03x0.03x0.04x0.07x0.12x0.28x
Equity ratio77.4%75.4%78.2%72.3%65.6%62.1%
Interest coverage41.54x43.04x33.12x37.97x15.48x11.73x
R&D as a share of sales7.6%8.7%9.7%7.4%7.2%7.5%
Buybacks as a share of market value0.1%-0.3%0.0%-24.1%19.9%-2.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.7%-0.6%0.5%
Operating income-11.8%3.1%-7.3%
Net income-3.6%11.5%-4.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.9%28.1%26.9%27.0%
Operating margin7.1%8.0%7.9%8.6%
Net margin7.7%7.6%7.5%6.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings18.723.634.814.110.325.124.331.037.5—
Price to sales1.61.62.41.11.01.21.31.41.82.9

Dividends and splits

Per share, in the currency the company pays

Paid for 23 years. Last went ex-dividend on 11 Jun 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year1.201.101.401.301.0941.1060.8480.754
  • 1.15-for-1 split · 1 Jul 2009
  • 11-for-10 split · 19 Jul 2007
  • 1.03-for-1 split · 14 Jun 2006
  • 1.162-for-1 split · 14 Jul 2004
  • 1.148-for-1 split · 17 Jul 2003
  • 1.31-for-1 split · 4 Jul 2002

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.